|
H1N1 vaccine2 |
Seasonal influenza vaccine2 |
Age group |
Male |
Female |
Overall |
Doses
Administered3
(million) |
Rate4 |
Male |
Female |
Overall |
Doses administered3
(million) |
Rate4 |
No. |
% |
No. |
% |
No. |
% |
No. |
% |
No. |
% |
No. |
% |
<17 |
7 |
35.0 |
10 |
22.2 |
17 |
26.2 |
19.0 |
0.89 |
9 |
40.9 |
7 |
19.4 |
16 |
27.6 |
26.3 |
0.61 |
18-49 |
8 |
40.0 |
28 |
62.2 |
36 |
55.3 |
13.5 |
2.67* |
8 |
36.4 |
22 |
61.1 |
30 |
51.7 |
31.9 |
0.94 |
50-64 |
5 |
25.0 |
7 |
15.6 |
12 |
18.5 |
6.2 |
1.94* |
5 |
22.7 |
6 |
16.7 |
11 |
19.0 |
21.3 |
0.52 |
>65 |
0 |
0 |
0 |
0 |
0 |
0 |
4.7 |
0 |
0 |
0 |
1 |
2.8 |
1 |
1.7 |
22.7 |
0.04 |
Total |
20 |
100.0 |
45 |
100.0 |
65 |
100.0 |
43.4 |
1.50* |
22 |
100.0 |
36 |
100.0 |
58 |
100.0 |
102.2 |
0.57 |
1Reports to VAERS received from July 1, 2009 through January 31, 2010 and vaccinated by November 30, 2009
2Simultaneous administration of seasonal influenza and 2009-H1N1 vaccines were included
3Based on data from the National 2009 H1N1 Flu Survey and 2010 U. S. Census
4Per million vaccine doses administered
*Significant difference (p<0.05) in reporting rates when compared to seasonal influenza vaccine |
